Marker Therapeutics, Inc.
At Close: 4:00 PM
After Market: 8:19 PM
MRKR Stock Price Graph
MRKR Stock Price Today
Marker Therapeutics, Inc. (MRKR) stock declined over -21.67% intraday to trade at $0.94 a share on NASDAQ. The stock opened with a loss of -1.67% at $1.18 and touched an intraday high of $1.232, falling -21.67% against the last close of $1.2. The Marker Therapeutics, Inc. in stock market went to a low of $0.881 during the session.
MRKR Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
3200 Southwest Freeway
Houston, TX 77027
Contact #:713 400 6400
Sales or Revenue$6.95 Million
5Y Sales Change-
Fiscal Year EndsDec. 2021
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill tumor cells expressing tumor-associated antigens. The company's MultiTAA-specific T cell therapies include autologous T cells for the treatment of lymphoma, and various solid tumors; allogeneic T cells for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia; and off-the-shelf products in various indications. It is also developing TPIV100/110, a peptide-based immunotherapeutic vaccines for the treatment of breast and ovarian cancer cells; and TPIV200, which is in Phase 2 clinical trial for the treatment of breast and ovarian cancers. The company was founded in 1999 and is headquartered in Houston, Texas.
Frequently Asked Questions
What is the current Marker Therapeutics, Inc. (MRKR) stock price?
Marker Therapeutics, Inc. (NASDAQ: MRKR) stock price is $0.94 in the last trading session. During the trading session, MRKR stock reached the peak price of $1.232 while $0.881 was the lowest point it dropped to. The percentage change in MRKR stock occurred in the recent session was -21.67% while the dollar amount for the price change in MRKR stock was -$0.26.
MRKR's industry and sector of operation?
The NASDAQ listed MRKR is part of Biotechnology industry that operates in the broader Health Care sector. Marker Therapeutics, Inc. , a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States.
Who are the executives of MRKR?
Dr. Juan F. Vera M.D.
Co-Founder, Chief Operating Officer, Chief Scientific Officer & Director
Mr. Peter L. Hoang MBA
Pres, Chief Executive Officer & Director
Mr. Edmund Cheung
Vice President of HR
Dr. Robert Z. Florkiewicz Sr.
Senior Director of Molecular Biology & Virology
How MRKR did perform over past 52-week?
MRKR's closing price is 0.07% higher than its 52-week low of $0.881 where as its distance from 52-week high of $6.6 is -0.86%.
How many employees does MRKR have?
Number of MRKR employees currently stands at 56. MRKR operates from 3200 Southwest Freeway, Suite 2500, Houston, TX 77027, United States.
Link for MRKR official website?
Official Website of MRKR is: https://www.markertherapeutics.com
How do I contact MRKR?
MRKR could be contacted at phone #713 400 6400 and can also be accessed through its website. MRKR operates from 3200 Southwest Freeway, Suite 2500, Houston, TX 77027, United States.
How many shares of MRKR are traded daily?
MRKR stock volume for the day was 346,461 shares. The average number of MRKR shares traded daily for last 3 months was 46.56 Thousands.
What is the market cap of MRKR currently?
The market value of MRKR currently stands at $10.96 Million with its latest stock price at $0.94 and 83.6 Million of its shares outstanding.